Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2165151
Max Phase: Preclinical
Molecular Formula: C19H18N2O2S
Molecular Weight: 338.43
Molecule Type: Small molecule
Associated Items:
ID: ALA2165151
Max Phase: Preclinical
Molecular Formula: C19H18N2O2S
Molecular Weight: 338.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cn1cccc1S(=O)(=O)Cc1ccccc1/N=C/c1ccccc1
Standard InChI: InChI=1S/C19H18N2O2S/c1-21-13-7-12-19(21)24(22,23)15-17-10-5-6-11-18(17)20-14-16-8-3-2-4-9-16/h2-14H,15H2,1H3/b20-14+
Standard InChI Key: MZPPEUXKPFMFFP-XSFVSMFZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 338.43 | Molecular Weight (Monoisotopic): 338.1089 | AlogP: 3.75 | #Rotatable Bonds: 5 |
Polar Surface Area: 51.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.13 | CX LogP: 3.96 | CX LogD: 3.96 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.67 | Np Likeness Score: -1.22 |
1. Koutsoumpli GE, Dimaki VD, Thireou TN, Eliopoulos EE, Labrou NE, Varvounis GI, Clonis YD.. (2012) Synthesis and study of 2-(pyrrolesulfonylmethyl)-N-arylimines: a new class of inhibitors for human glutathione transferase A1-1., 55 (15): [PMID:22849615] [10.1021/jm300385f] |
Source(1):